The authors respond to critiques regarding their COPD diagnostic schema, specifically concerning the role of CT scans. They concur that low-dose CT and chest radiography warrant testing within the schema. The schema's primary function remains diagnosing individuals previously undiagnosed, as it still relies on spirometry for airflow obstruction confirmation. Their study indicates the new schema won't miss any COPD cases already diagnosed. The "minor diagnostic category" includes those with high suspicion but lacking spirometry results or meeting airflow obstruction criteria. The authors disagree with renaming this to "chronic nonspecific lung disease." Individuals in this category may have significant lung function loss or other measurable abnormalities. Close monitoring and tailored treatment, based on symptoms and lung function, are crucial. Some individuals in the minor group were inappropriately prescribed inhaled corticosteroids. These therapies should be based on signs of frequent exacerbations. The core focus is accurately diagnosing and managing COPD.